Eliem Therapeutics News

Eliem Therapeutics | DEFA14A: Others

Apr 11 08:14 ET

Eliem Therapeutics | 8-K: Current report

Apr 11 08:04 ET

Eliem Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 28 16:35 ET

Eliem Therapeutics | 8-K: Current report

Mar 19 13:33 ET

Eliem Therapeutics | 8-K: Current report

Jul 20, 2023 06:55 ET

Eliem Therapeutics | 8-K: Current report

May 19, 2023 16:45 ET

Eliem Therapeutics | 8-K: Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights

May 11, 2023 16:12 ET

Eliem Therapeutics | DEFA14A: Others

Apr 6, 2023 16:10 ET

Eliem Therapeutics | DEF 14A: Definitive proxy statements

Apr 6, 2023 16:05 ET

Eliem Therapeutics | 8-K: Current report

Mar 16, 2023 16:30 ET

Eliem Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 6, 2023 16:59 ET

Eliem Therapeutics | 8-K: Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights

Mar 6, 2023 16:52 ET

Eliem Therapeutics | 8-K: Current report

Feb 13, 2023 21:09 ET

Eliem Therapeutics | 8-K: Current report

Jan 24, 2023 16:21 ET

Eliem Therapeutics | 8-K: Current report

Dec 20, 2022 16:02 ET

Eliem Therapeutics | 8-K: Current report

Nov 14, 2022 06:10 ET

Eliem Therapeutics | 8-K: Current report

Oct 5, 2022 07:47 ET

Eliem Therapeutics | 8-K: Current report

Aug 15, 2022 06:15 ET

Eliem Therapeutics | 8-K: Current report

Jul 18, 2022 17:21 ET

Eliem Therapeutics | 8-K: Current report

May 24, 2022 16:13 ET